v3.26.1
Segment (Tables)
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information by Segment

 

Clinical Research Segment

 

 

Three Months Ended

 

 

March 31,

 

 

2026

 

 

2025

 

 

 

 

 

 

 

 

(in thousands)

 

Operating expenses:

 

 

 

 

 

Direct program expense

$

6,717

 

 

$

7,872

 

Indirect program expense

 

474

 

 

 

526

 

Workforce salaries and benefits

 

4,460

 

 

 

4,407

 

Share-based compensation expense

 

2,780

 

 

 

2,745

 

General corporate expenses

 

1,184

 

 

 

1,450

 

Segment net loss

 

15,615

 

 

 

17,000

 

Reconciliation of loss:

 

 

 

 

 

Interest income

 

(458

)

 

 

(1,075

)

Adjustments and reconciling items

 

(458

)

 

 

(1,075

)

Net loss

$

15,157

 

 

$

15,925